JP2014534215A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014534215A5 JP2014534215A5 JP2014538834A JP2014538834A JP2014534215A5 JP 2014534215 A5 JP2014534215 A5 JP 2014534215A5 JP 2014538834 A JP2014538834 A JP 2014538834A JP 2014538834 A JP2014538834 A JP 2014538834A JP 2014534215 A5 JP2014534215 A5 JP 2014534215A5
- Authority
- JP
- Japan
- Prior art keywords
- indazol
- composition
- pyrimidinyl
- methylamino
- dimethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161553454P | 2011-10-31 | 2011-10-31 | |
| US61/553,454 | 2011-10-31 | ||
| PCT/US2012/060361 WO2013066616A1 (en) | 2011-10-31 | 2012-10-16 | Pazopanib formulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017093456A Division JP6423484B2 (ja) | 2011-10-31 | 2017-05-10 | パゾパニブ製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014534215A JP2014534215A (ja) | 2014-12-18 |
| JP2014534215A5 true JP2014534215A5 (enExample) | 2015-11-12 |
| JP6200893B2 JP6200893B2 (ja) | 2017-09-20 |
Family
ID=48192602
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014538834A Expired - Fee Related JP6200893B2 (ja) | 2011-10-31 | 2012-10-16 | パゾパニブ製剤 |
| JP2017093456A Expired - Fee Related JP6423484B2 (ja) | 2011-10-31 | 2017-05-10 | パゾパニブ製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017093456A Expired - Fee Related JP6423484B2 (ja) | 2011-10-31 | 2017-05-10 | パゾパニブ製剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9278099B2 (enExample) |
| EP (1) | EP2773204A4 (enExample) |
| JP (2) | JP6200893B2 (enExample) |
| KR (1) | KR101993436B1 (enExample) |
| CN (1) | CN104254249B (enExample) |
| AU (1) | AU2012332952B2 (enExample) |
| BR (1) | BR112014010551A2 (enExample) |
| CA (1) | CA2852912A1 (enExample) |
| HK (1) | HK1201685A1 (enExample) |
| IN (1) | IN2014CN02850A (enExample) |
| RU (1) | RU2616500C2 (enExample) |
| WO (1) | WO2013066616A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA201502073B (en) * | 2014-03-28 | 2016-03-30 | Cipla Ltd | Pharmaceutical composition |
| JP7108018B2 (ja) | 2017-04-17 | 2022-07-27 | イエール ユニバーシティ | 急性肺傷害を処置または予防する化合物、組成物および方法 |
| WO2019053500A1 (en) | 2018-04-17 | 2019-03-21 | Alvogen Malta Operations (Row) Ltd | PHARMACEUTICAL COMPOSITION OF SOLID DOSAGE FORM CONTAINING PAZOPANIB AND PROCESS FOR PREPARING THE SAME |
| MX395463B (es) | 2018-04-24 | 2025-03-25 | Shionogi & Co | Forma de dosificacion solida que tiene excelente estabilidad |
| KR102501180B1 (ko) | 2018-04-24 | 2023-02-21 | 시오노기세야쿠 가부시키가이샤 | 안정성이 우수한 고형 제제 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH675537A5 (enExample) * | 1988-03-25 | 1990-10-15 | Ciba Geigy Ag | |
| ES2054089T3 (es) | 1988-11-10 | 1994-08-01 | Ciba Geigy Ag | Formulaciones orales liquidas. |
| ES2556946T3 (es) * | 2000-12-21 | 2016-01-21 | Novartis Ag | Pirimidinaminas como moduladores de la angiogénesis |
| ES2201932B2 (es) * | 2001-11-23 | 2005-03-16 | Glaxo Group Limited | Composicion farmaceutica. |
| RU2255730C1 (ru) * | 2003-10-14 | 2005-07-10 | Федеральное государственное унитарное предприятие "Всероссийкий научный центр по безопасности биологически активных веществ" (ФГУП "ВНЦ БАВ") | Стабильная фармацевтическая суспензия азитромицина и способ ее получения |
| TWI374883B (en) * | 2004-08-16 | 2012-10-21 | Theravance Inc | Crystalline form of a biphenyl compound |
| TW200740820A (en) * | 2005-07-05 | 2007-11-01 | Takeda Pharmaceuticals Co | Fused heterocyclic derivatives and use thereof |
| WO2007064753A2 (en) * | 2005-11-29 | 2007-06-07 | Smithkline Beecham Corporation | Cancer treatment method |
| PL1968594T3 (pl) * | 2005-11-29 | 2011-03-31 | Glaxosmithkline Llc | Leczenie zaburzeń neowaskularyzacyjnych oka, takich jak zwyrodnienie plamki żółtej, rozszerzenie naczyń siatkówki w zespole Hippla i Lindaua, zapalenie błony naczyniowej oka i obrzęk plamki |
| AR059066A1 (es) * | 2006-01-27 | 2008-03-12 | Amgen Inc | Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf) |
| RU2488393C2 (ru) * | 2007-11-12 | 2013-07-27 | Новартис Аг | Жидкие композиции, включающие валсартан |
| CL2008000374A1 (es) * | 2008-02-05 | 2008-04-04 | Igloo Zone Chile S A | Composicion farmaceutica que comprende un polvo para suspension oral de tacrolimus o una de sus sales, hidratos o solvatos y excipientes farmaceuticamente aceptables; procedimiento de preparacion de dicha composicion farmaceutica; y uso para la preve |
| JP2011516607A (ja) * | 2008-04-15 | 2011-05-26 | サーコード コーポレイション | 胃腸系へのｌｆａ−１アンタゴニストの送達 |
| WO2010037095A2 (en) * | 2008-09-29 | 2010-04-01 | Nometics | Agents and methods for the treatment of cancer |
| US20100291025A1 (en) * | 2009-04-13 | 2010-11-18 | Auspex Pharmaceuticals, Inc. | Indazole inhibitors of tyrosine kinase |
| EP2298321A1 (en) * | 2009-08-26 | 2011-03-23 | Nordic Pharma | Novel pharmaceutical compositions for treating IBD |
| US8501811B2 (en) * | 2010-06-17 | 2013-08-06 | Washington University | TASPASE1 inhibitors and their uses |
-
2012
- 2012-10-16 AU AU2012332952A patent/AU2012332952B2/en not_active Ceased
- 2012-10-16 JP JP2014538834A patent/JP6200893B2/ja not_active Expired - Fee Related
- 2012-10-16 BR BR112014010551A patent/BR112014010551A2/pt not_active IP Right Cessation
- 2012-10-16 HK HK15102188.1A patent/HK1201685A1/xx unknown
- 2012-10-16 KR KR1020147014294A patent/KR101993436B1/ko not_active Expired - Fee Related
- 2012-10-16 US US14/353,141 patent/US9278099B2/en active Active
- 2012-10-16 CN CN201280052742.8A patent/CN104254249B/zh not_active Expired - Fee Related
- 2012-10-16 IN IN2850CHN2014 patent/IN2014CN02850A/en unknown
- 2012-10-16 RU RU2014115289A patent/RU2616500C2/ru active
- 2012-10-16 WO PCT/US2012/060361 patent/WO2013066616A1/en not_active Ceased
- 2012-10-16 CA CA2852912A patent/CA2852912A1/en not_active Abandoned
- 2012-10-16 EP EP12844715.8A patent/EP2773204A4/en not_active Withdrawn
-
2016
- 2016-01-13 US US14/994,497 patent/US10080802B2/en active Active
-
2017
- 2017-05-10 JP JP2017093456A patent/JP6423484B2/ja not_active Expired - Fee Related
-
2018
- 2018-08-22 US US16/109,143 patent/US10596263B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200744677A (en) | Compositions and methods for preparation of poorly water soluble drugs with increased stability | |
| MX2009000035A (es) | Formulaciones de agente activo, procedimientos de preparacion y procedimientos de uso. | |
| JP2016516765A5 (enExample) | ||
| JP2013525493A5 (enExample) | ||
| GEP20125628B (en) | Pharmaceutical compositions containing antagonist anti-cd40 antibody | |
| JP2018021007A5 (enExample) | ||
| AR043863A1 (es) | Composiciones que contienen piperacilina y tazobactam, utiles para inyeccioines | |
| CA2505742A1 (en) | Pharmaceutical compositions comprising a basic drug, a water soluble acid and a surfactant | |
| HRP20171256T1 (hr) | Farmaceutski pripravci karbetocina | |
| EP3283051A1 (en) | Self-foaming compositions and methods | |
| JP2012505172A5 (enExample) | ||
| JP2013535472A5 (enExample) | ||
| FI3943070T3 (fi) | Pitkävaikutteisia bedakiliiniformulaatioita | |
| MX2011005643A (es) | Formas de dosificacion oral de bendamustina. | |
| TW200609001A (en) | Particulate-stabilized injectable pharmaceutical compositions of posaconasole | |
| CA2961528A1 (en) | Long acting pharmaceutical compositions | |
| RU2014115289A (ru) | Композиция пазопаниба | |
| MX2014001065A (es) | Formulaciones de (trimetoxifenilamino) pirimidilino nuevas. | |
| MX2025014916A (es) | Lípidos para usarse en nanopartículas lipídicas | |
| JP5988855B2 (ja) | 水性眼科組成物 | |
| JP2008538751A5 (enExample) | ||
| TW200640459A (en) | Particulate-stabilized injectable pharmaceutical compositions of posaconazole | |
| JP5242430B2 (ja) | 歯磨き組成物 | |
| JP5509631B2 (ja) | 口腔用塗布ゲル剤組成物 | |
| MA32722B1 (fr) | Formulation galénique renfermant de l'aliskirène et procédé associé de préparation par granulation par fusion-extrusion |